Scoop
ActiveAutomating regulatory submissions for life sciences
About
We’re building AI agents that speed up drug trials by automating the manual consolidation and document prep required for every IND submission. Today, biotechs spend months stitching together reports from contractors and internal teams just to file and get to their first-in-human trial.
Founders · 2
CEO and Co-founder @ Scoop. Previously at Persona and Dropbox. Working on Scoop to help speed up drug trials, starting with IND filings, to help companies bring life-saving treatments to market faster.
Co-founder and CTO @ Scoop. Ex-Google Search applied AI (Gemini CoT), supported IND and Phase III clinical trial design for ALS therapy at Corestem, prev at Genentech and CJ Bioscience. MS in Computer Science and Biotechnology from Penn.
Launch
We create ready-to-submit regulatory documents so new therapies can reach clinical trials faster
Scoop uses AI to automate the preparation and maintenance of regulatory documents for human drug trials, turning IND submissions from months into days by generating draft documents, maintaining consistency with new data, and flagging items for review for biotech and CRO teams.
Related startups
Full stack AI Agents accelerating Biopharma R&D
Agent Platform for Life Sciences
